Role of IGF-1 in age-related loss of skeletal muscle mass and function

Sarcopenia - Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments

Volumn , Issue , 2011, Pages 393-418

  McMahon, Chris D ^b   Shavlakadze, Thea ^a   Grounds, Miranda D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b RUAKURA RESEARCH CENTRE   (New Zealand)

Author keywords

Growth hormone; Insulin like growth factor 1 (IGF 1); Muscle atrophy; Sarcopenia; Skeletal muscle wasting

Indexed keywords

EID: 82555162187     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-9713-2_17     Document Type: Chapter

References (153)

1. Accili, D., Nakae, J., Kim, J. J., Park, B. C., Rother, K. I. (1999). Targeted gene mutations define the roles of insulin and IGF-I receptors in mouse embryonic development. Journal of Pediatric Endocrinology & Metabolism, 12, 475-485.
2. Arking, D. E., Krebsova, A., Macek, M. Sr., Macek, M. Jr., Arking, A., Mian, I. S., Fried, L, Hamosh, A., Dey, S., Mcintosh, I., Dietz, H. C. (2002). Association of human aging with a functional variant of klotho. Proceedings of the National Academy of Sciences of the United States of America, 99, 856-861.
3. Arking, D. E., Atzmon, G., Arking, A., Barzilai, N., Dietz, H. C. (2005). Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circulation Research, 96, 412-418.
4. Arthur, P. G., Grounds, M. D., Shavlakadze, T. (2008). Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions. Current Opinion in Clinical Nutrition and Metabolic Care, 11, 408-416.
5. Bartke, A. (2006). Long-lived Klotho mice: new insights into the roles of IGF-1 and insulin in aging. Trends in Endocrinology and Metabolism, 17, 33-35.
6. Bartke, A., Brown-Borg, H., Mattison, J., Kinney, B., Hauck, S., Wright, C. (2001). Prolonged longevity of hypopituitary dwarf mice. Experimental Gerontology, 36, 21-28.
7. Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., Yancopoulos, G. D. (2001). Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nature Cell Biology, 3, 1014-1019.
8. Boland, R., DE Boland, A. R., Buitrago, C., Morelli, S., Santillan, G., Vazquez, G., Capiati, D., Baldi, C. (2002). Non-genomic stimulation of tyrosine phosphorylation cascades by 1, 25(OH) (2)D(3) by VDR-dependent and -independent mechanisms in muscle cells. Steroids, 67, 477-482.
9. Boney, C. M., Sekimoto, H., Gruppuso, P. A., Frackelton, A. R. Jr. (2001). Src family tyrosine kinases participate in insulin-like growth factor I mitogenic signaling in 3T3-L1 cells. Cell Growth & Differentiation, 12, 379-386.
10. Borst, S. E. & Lowenthal, D. T. (1997). Role of IGF-I in muscular atrophy of aging. Endocrine, 7, 61-63.
11. Breier, B. H., Bass, J. J., Butler, J. H., Gluckman, P. D. (1986). The somatotrophic axis in young steers: influence of nutritional status on pulsatile release of growth hormone and circulating concentrations of insulin-like growth factor 1. The Journal of Endocrinology, 111, 209-215.
12. Breier, B. H., Gluckman, P. D., Bass, J. J. (1988). Influence of nutritional status and oestradiol-17 beta on plasma growth hormone, insulin-like growth factors-I and -II and the response to exogenous growth hormone in young steers. The Journal of Endocrinology, 118, 243-250.
13. Briefel, R. R., Mcdowell, M. A., Alaimo, K., Caughman, C. R., Bischof, A. L., Carroll, M. D., Johnson, C. L. (1995). Total energy intake of the US population: The third National Health and Nutrition Examination Survey, 1988-1991. The American Journal of Clinical Nutrition, 62, 1072S-1080S.
14. Broussard, S. R., Mccusker, R. H., Novakofski, J. E., Strle, K., Shen, W. H., Johnson, R. W., Freund, G. G., Dantzer, R., Kelley, K. W. (2003). Cytokine-hormone interactions: Tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin- like growth factor I receptor in myoblasts. Endocrinology, 144, 2988-2996.
15. Broussard, S. R., Mccusker, R. H., Novakofski, J. E., Strle, K., Shen, W. H., Johnson, R. W., Dantzer, R., Kelley, K. W. (2004). IL-1beta impairs insulin-like growth factor I-induced differentiation and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. Journal of Immunology, 172, 7713-7720.
16. Bruunsgaard, H. & Pedersen, B. K. (2003). Age-related inflammatory cytokines and disease. Immunology and Allergy Clinics of North America, 23, 15-39.
17. Buffenstein, R. & Pinto, M. (2009). Endocrine function in naturally long-living small mammals. Molecular and Cellular Endocrinology, 299, 101-111.
18. Buitrago, C., Vazquez, G., De Boland, A. R., Boland, R. L. (2000). Activation of Src kinase in skeletal muscle cells by 1, 1, 25-(OH(2))-vitamin D(3) correlates with tyrosine phosphorylation of the vitamin D receptor (VDR) and VDR-Src interaction. Journal of Cellular Biochemistry, 79, 274-281.
19. Campbell, W. W. & Leidy, H. J. (2007). Dietary protein and resistance training effects on muscle and body composition in older persons. Journal of the American College of Nutrition, 26, 696S-703S.
20. Castaneda, C., Gordon, P. L., Fielding, R. A., Evans, W. J., Crim, M. C. (2000). Marginal protein intake results in reduced plasma IGF-I levels and skeletal muscle fiber atrophy in elderly women. The Journal of Nutrition, Health & Aging, 4, 85-90.
21. Ceda, G. P., Dall'Aglio, E., Maggio, M., Lauretani, F., Bandinelli, S., Falzoi, C., Grimaldi, W., Ceresini, G., Corradi, F., Ferrucci, L., Valenti, G., Hoffman, A. R. (2005). Clinical implications of the reduced activity of the GH-IGF-I axis in older men. Journal of Endocrinological Investigation, 28, 96-100.
22. Chakravarthy, M. V., Fiorotto, M. L., Schwartz, R. J., Booth, F. W. (2001). Long-term insulin-like growth factor-I expression in skeletal muscles attenuates the enhanced in vitro proliferation ability of the resident satellite cells in transgenic mice. Mechanisms of Ageing and Development, 122, 1303-1320.
23. Chapman, I. M. (2006). Nutritional disorders in the elderly. The Medical Clinics of North America, 90, 887-907.
24. Chapman, I. M. (2007). The anorexia of aging. Clinics in Geriatric Medicine, 23, 735-756.
25. Chapman, I. M., Macintosh, C. G., Morley, J. E., Horowitz, M. (2002). The anorexia of ageing. Biogerontology, 3, 67-71.
26. Chen, C. D., Podvin, S., Gillespie, E., Leeman, S. E., Abraham, C. R. (2007). Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proceedings of the National Academy of Sciences of the United States of America, 104, 19796-19801.
27. Colman, R. J., Beasley, T. M., Allison, D. B., Weindruch, R. (2008). Attenuation of sarcopenia by dietary restriction in rhesus monkeys. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 63, 556-559.
28. Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., Weindruch, R. (2009). Caloric restriction delays disease onset and mortality in rhesus monkeys. Science, 325, 201-204.
29. Coolican, S. A., Samuel, D. S., Ewton, D. Z., Mcwade, F. J., Florini, J. R. (1997). The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. The Journal of Biological Chemistry, 272, 6653-6662.
30. Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., Levey, A. S. (2003). Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. American Journal of Kidney Diseases, 41, 1-12.
31. Coresh, J., Byrd-Holt, D., Astor, B. C., Briggs, J. P., Eggers, P. W., Lacher, D. A., Hostetter, T. H. (2005). Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. Journal of the American Society of Nephrology, 16, 180-188.
32. Corpas, E., Harman, S. M., Blackman, M. R. (1993). Human growth hormone and human aging. Endocrine Reviews, 14, 20-39.
33. Cree, M. G., Newcomer, B. R., Katsanos, C. S., Sheffield-Moore, M., Chinkes, D., Aarsland, A., Urban, R., Wolfe, R. R. (2004). Intramuscular and liver triglycerides are increased in the elderly. The Journal of Clinical Endocrinology and Metabolism, 89, 3864-3871.
34. Dardevet, D., Sornet, C., Attaix, D., Baracos, V. E., Grizard, J. (1994). Insulin-like growth factor-1 and insulin resistance in skeletal muscles of adult and old rats. Endocrinology, 134, 1475-1484.
35. Dawson-Hughes, B., Harris, S. S., Rasmussen, H., Song, L., Dallal, G. E. (2004). Effect of dietary protein supplements on calcium excretion in healthy older men and women. The Journal of Clinical Endocrinology and Metabolism, 89, 1169-1173.
36. Dennis, R. A., Przybyla, B., Gurley, C., Kortebein, P. M., Simpson, P., Sullivan, D. H., Peterson, C. A. (2008). Aging alters gene expression of growth and remodeling factors in human skeletal muscle both at rest and in response to acute resistance exercise. Physiological Genomics, 32, 393-400.
37. Dikkes, Pdbj, Guo, W. H., Chao, C., Hemond, P., Yoon, K., Zurakowski, D., Lopez, M. F. (2007). IGF2 knockout mice are resistant to kainic acid-induced seizures and neurodegeneration. Brain Research, 1175, 85-95.
38. Ebert, R., Schutze, N., Adamski, J., Jakob, F. (2006). Vitamin D signaling is modulated on multiple levels in health and disease. Molecular and Cellular Endocrinology, 248, 149-159.
39. Edstrom, E. & Ulfhake, B. (2005). Sarcopenia is not due to lack of regenerative drive in senescent skeletal muscle. Aging Cell, 4, 65-77.
40. Edstrom, E., Altun, M., Hagglund, M., Ulfhake, B. (2006). Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 61, 663-674.
41. Edstrom, E., Altun, M., Bergman, E., Johnson, H., Kullberg, S., Ramirez-Leon, V., Ulfhake, B. (2007). Factors contributing to neuromuscular impairment and sarcopenia during aging. Physiology & Behavior, 92, 129-135.
42. Engert, J. C., Berglund, E. B., Rosenthal, N. (1996). Proliferation precedes differentiation in IGFI- stimulated myogenesis. The Journal of Cell Biology, 135, 431-440.
43. Evans, W. J. (2004). Protein nutrition, exercise and aging. Journal of the American College of Nutrition, 23, 601S-609S.
44. Florini, J. R., Prinz, P. N., Vitiello, M. V., Hintz, R. L. (1985). Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone. Journal of Gerontology, 40, 2-7.
45. Florini, J. R., Ewton, D. Z., Roof, S. L. (1991). Insulin-like growth factor-1 stimulates terminal myogenic differentiation by induction of myogenin gene expression. Molecular Endocrinology, 5, 718-724.
46. Florini, J. R., Ewton, D. Z., Coolican, S. A. (1996). Growth hormone and the insulin-like growth factor system in myogenesis. Endocrine Reviews, 17, 481-517.
47. Fontana, L., Weiss, E. P., Villareal, D. T., Klein, S., Holloszy, J. O. (2008). Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell, 7, 681-687.
48. Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., Vigneri, R. (1999). Insulin receptor isoform A, a newly recognized, high-affinity insulinlike growth factor II receptor in fetal and cancer cells. Molecular and Cellular Biology, 19, 3278-3288.
49. Frost, R. A., Nystrom, G. J., Lang, C. H. (2003). Tumor necrosis factor-alpha decreases insulinlike growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway. Endocrinology, 144, 1770-1779.
50. Giustina, A. & Veldhuis, J. D. (1998). Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Reviews, 19, 717-797.
51. Glass, D. J. (2005). Skeletal muscle hypertrophy and atrophy signaling pathways. The International Journal of Biochemistry & Cell Biology, 37, 1974-1984.
52. Goldspink, G. (2005). Mechanical signals, IGF-I gene splicing, and muscle adaptation. Physiology (Bethesda), 20, 232-238.
53. Goodpaster, B. H. & Brown, N. F. (2005). Skeletal muscle lipid and its association with insulin resistance: What is the role for exercise? Exercise and Sport Sciences Reviews, 33, 150-154.
54. Goodpaster, B. H., HE, J., Watkins, S., Kelley, D. E. (2001). Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. The Journal of Clinical Endocrinology and Metabolism, 86, 5755-5761.
55. Grounds, M. D. (2002). Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling. Biogerontology, 3, 19-24.
56. Grounds, M. D., Radley, H. G., Gebski, B. G., Bogoyevitch, M. A., Shavlakadze, T. (2008). Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle. Clinical and Experimental Pharmacology & Physiology, 35, 846-851.
57. Hallfrisch, J., Muller, D., Drinkwater, D., Tobin, J., Andres, R. (1990). Continuing diet trends in men: The Baltimore longitudinal study of aging (1961-1987). Journal of Gerontology, 45, M186-M191.
58. Hameed, M., Orrell, R. W., Cobbold, M., Goldspink, G., Harridge, S. D. (2003). Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. Journal de Physiologie, 547, 247-254.
59. Hameed, M., Toft, A. D., Pedersen, B. K., Harridge, S. D., Goldspink, G. (2008). Effects of eccentric cycling exercise on IGF-I splice variant expression in the muscles of young and elderly people. Scandinavian Journal of Medicine & Science in Sports, 18, 447-452.
60. Hayden, J. M., Marten, N. W., Burke, E. J., Straus, D. S. (1994). The effect of fasting on insulinlike growth factor-I nuclear transcript abundance in rat liver. Endocrinology, 134, 760-768.
61. Herrington, J., Smit, L. S., Schwartz, J., Carter-SU, C. (2000). The role of STAT proteins in growth hormone signaling. Oncogene, 19, 2585-2597.
62. Hill, M. & Goldspink, G. (2003). Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. The Journal of Physiology, 549, 409-418.
63. HO, K. Y., Evans, W. S., Blizzard, R. M., Veldhuis, J. D., Merriam, G. R., Samojlik, E., Furlanetto, R., Rogol, A. D., Kaiser, D. L., Thorner, M. O. (1987). Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. The Journal of Clinical Endocrinology and Metabolism, 64, 51-58.
64. Hornberger, T. A., Stuppard, R., Conley, K. E., Fedele, M. J., Fiorotto, M. L., Chin, E. R., Esser, K. A. (2004). Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- And growth factor-independent mechanism. The Biochemical Journal, 380, 795-804.
65. Huang, X., Blackman, M. R., Herreman, K., Pabst, K. M., Harman, S. M., Caballero, B. (2005). Effects of growth hormone and/or sex steroid administration on whole-body protein turnover in healthy aged women and men. Metabolism, 54, 1162-1167.
66. Huffman, D. M., Moellering, D. R., Grizzle, W. E., Stockard, C. R., Johnson, M. S., Nagy, T. R. (2008). Effect of exercise and calorie restriction on biomarkers of aging in mice. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 294, R1618-R1627.
67. Hwee, D. T. & Bodine, S. C. (2009). Age-related deficit in load-induced skeletal muscle growth. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 64, 618-628.
68. Hypponen, E., Boucher, B. J., Berry, D. J., Power, C. (2008). 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes, 57, 298-305.
69. Imai, M., Ishikawa, K., Matsukawa, N., Kida, I., Ohta, J., Ikushima, M., Chihara, Y., Rui, X., Rakugi, H., Ogihara, T. (2004). Klotho protein activates the PKC pathway in the kidney and testis and suppresses 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression. Endocrine, 25, 229-234.
70. Invidia, L., Salvioli, S., Altilia, S., Pierini, M., Panourgia, M. P., Monti, D., De Rango, F., Passarino, G., Franceschi, C. (2010). The frequency of Klotho KL-VS polymorphism in a large Italian population, from young subjects to centenarians, suggests the presence of specific time windows for its effect. Biogerontology, 11, 67-73.
71. Isgaard, J., Nilsson, A., Vikman, K., Isaksson, O. G. (1989). Growth hormone regulates the level of insulin-like growth factor-I mRNA in rat skeletal muscle. The Journal of Endocrinology, 120, 107-112.
72. Isley, W. L., Underwood, L. E., Clemmons, D. R. (1983). Dietary components that regulate serum somatomedin-C concentrations in humans. Journal of Clinical Investigation, 71, 175-182.
73. Janssen, H. C., Samson, M. M., Verhaar, H. J. (2002). Vitamin D deficiency, muscle function, and falls in elderly people. The American Journal of Clinical Nutrition, 75, 611-615.
74. Jeanplong, F., Bass, J. J., Smith, H. K., Kirk, S. P., Kambadur, R., Sharma, M., Oldham, J. M. (2003). Prolonged underfeeding of sheep increases myostatin and myogenic regulatory factor Myf-5 in skeletal muscle while IGF-I and myogenin are repressed. The Journal of Endocrinology, 176, 425-437.
75. Kaplan, S. A. & Cohen, P. (2007). The somatomedin hypothesis 2007: 50 years later. The Journal of Clinical Endocrinology and Metabolism, 92, 4529-4535.
76. Keisala, T., Minasyan, A., Lou, Y. R., Zou, J., Kalueff, A. V., Pyykko, I., Tuohimaa, P. (2009). Premature aging in vitamin D receptor mutant mice. The Journal of Steroid Biochemistry and Molecular Biology, 115, 91-97.
77. Khalil, D. A., Lucas, E. A., Juma, S., Smith, B. J., Payton, M. E., Arjmandi, B. H. (2002). Soy protein supplementation increases serum insulin-like growth factor-I in young and old men but does not affect markers of bone metabolism. The Journal of Nutrition, 132, 2605-2608.
78. Kim, J. H., Kwak, H. B., Leeuwenburgh, C., Lawler, J. M. (2008). Lifelong exercise and mild (8%) caloric restriction attenuate age-induced alterations in plantaris muscle morphology, oxidative stress and IGF-1 in the Fischer-344 rat. Experimental Gerontology, 43, 317-329.
79. Klover, P. & Hennighausen, L. (2007). Postnatal body growth is dependent on the transcription factors signal transducers and activators of transcription 5a/b in muscle: a role for autocrine/paracrine insulin-like growth factor I. Endocrinology, 148, 1489-1497.
80. Kofoed, E. M., Hwa, V., Little, B., Woods, K. A., Buckway, C. K., Tsubaki, J., Pratt, K. L., Bezrodnik, L., Jasper, H., Tepper, A., Heinrich, J. J., Rosenfeld, R. G. (2003). Growth hormone insensitivity associated with a STAT5B mutation. The New England Journal of Medicine, 349, 1139-1147.
81. Kuro-O, M. (2008). Klotho as a regulator of oxidative stress and senescence. Biological Chemistry, 389, 233-241.
82. Kuro-O, M. (2009). Klotho and aging. Biochim Biophys Acta, 1790(10), 1049-1058. [Epub ahead of print].
83. Kuro-O, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., Iwasaki, H., Iida, A., Shiraki-Iida, T., Nishikawa, S., Nagai, R., Nabeshima, Y. I. (1997). Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature, 390, 45-51.
84. Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., Mcguinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., Shimomura, I., Takayama, Y., Herz, J., Kahn, C. R., Rosenblatt, K. P., Kuro-O, M. (2005). Suppression of aging in mice by the hormone Klotho. Science, 309, 1829-1833.
85. Lai, K. M., Gonzalez, M., Poueymirou, W. T., Kline, W. O., NA, E., Zlotchenko, E., Stitt, T. N., Economides, A. N., Yancopoulo, G. D., Glass, D. J. (2004). Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Molecular and Cellular Biology, 24, 9295-9304.
86. Le Roith, D., Bondy, C., Yakar, S., Liu, J. L., Butler, A. (2001a). The somatomedin hypothesis: 2001. Endocrine Reviews, 22, 53-74.
87. Le Roith, D., Scavo, L., Butler, A. (2001b). What is the role of circulating IGF-I? Trends in Endocrinology and Metabolism, 12, 48-52.
88. Leger, B., Derave, W., DE Bock, K., Hespel, P., Russell, A. P. (2008). Human sarcopenia reveals an increase in Socs-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenation Research, 11, 163-175.
89. Lieskovska, J., Ling, Y., Badley-Clarke, J., Clemmons, D. R. (2006). The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells. The Journal of Biological Chemistry, 281, 25041-25053.
90. Lupu, F., Terwilliger, J. D., Lee, K., Segre, G. V., Efstratiadis, A. (2001). Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Developmental Biology, 229, 141-162.
91. Lynch, G. S., Shavlakadze, T., Grounds, M. D. (2005). Strategies to reduce age-related skeletal muscle wasting. In R. Sis (Ed.), Ageing interventions and therapies. Singapore: World Scientific Publishers.
92. Macintosh, B. R., Gardiner, P. F., Mccomas, A. J. (2006). Skeletal muscle form and function (2nd edn). Champaign, IL: Human Kinetics.
93. Maggio, M., Ble, A., Ceda, G. P., Metter, E. J. (2006). Decline in insulin-like growth factor-I levels across adult life span in two large population studies. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 61, 182-183.
94. Mahesh, S. & Kaskel, F. (2008). Growth hormone axis in chronic kidney disease. Pediatric Nephrology, 23, 41-48.
95. Mak, R. H., Cheung, W. W., Roberts, C. T. Jr. (2008). The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Hormone & IGF Research, 18, 17-25.
96. Marcell, T. J., Harman, S. M., Urban, R. J., Metz, D. D., Rodgers, B. D., Blackman, M. R. (2001). Comparison of GH, IGF-I, and testosterone with mRNA of receptors and myostatin in skeletal muscle in older men. American Journal of Physiology Endocrinology and Metabolism, 281, E1159-E1164.
97. Martin, F. C., Yeo, A. L., Sonksen, P. H. (1997). Growth hormone secretion in the elderly: ageing and the somatopause. Baillière's Clinical Endocrinology and Metabolism, 11, 223-250.
98. Mcmahon, C. D., Radcliff, R. P., Lookingland, K. J., Tucker, H. A. (2001). Neuroregulation of growth hormone secretion in domestic animals. Domestic Animal Endocrinology, 20, 65-87.
99. Messina, S., Bitto, A., Aguennouz, M., Minutoli, L., Monici, M. C., Altavilla, D., Squadrito, F., Vita, G. (2006). Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Experimental Neurology, 198, 234-241.
100. Morelli, S., Buitrago, C., Vazquez, G., De Boland, A. R., Boland, R. (2000). Involvement of tyrosine kinase activity in 1alpha, 25(OH)2-vitamin D3 signal transduction in skeletal muscle cells. The Journal of Biological Chemistry, 275, 36021-36028.
101. Morley, J. E. (1997). Anorexia of aging: physiologic and pathologic. The American Journal of Clinical Nutrition, 66, 760-773.
102. Musaro, A., Mccullagh, K., Paul, A., Houghton, L., Dobrowolny, G., Molinaro, M., Barton, E. R., Sweeney, H. L., Rosentha, N. (2001). Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nature Genetics, 27, 195-200.
103. O'Connor, K. G., Tobin, J. D., Harman, S. M., Plato, C. C., Roy, T. A., Sherman, S. S., Blackman, M. R. (1998). Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 53, M176-M182.
104. Oldham, J. M., Martyn, J. A., Kirk, S. P., Napier, J. R., Bass, J. J. (1996). Regulation of type 1 insulin-like growth factor (IGF) receptors and IGF-I mRNA by age and nutrition in ovine skeletal muscles. The Journal of Endocrinology, 148, 337-346.
105. Oliver, W. T., Rosenberger, J., Lopez, R., Gomez, A., Cummings, K. K., Fiorotto, M. L. (2005). The local expression and abundance of insulin-like growth factor (IGF) binding proteins in skeletal muscle are regulated by age and gender but not local IGF-1 in vivo. Endocrinology, 146, 5455-5462.
106. Paddon-Jones, D. & Rasmussen, B. B. (2009). Dietary protein recommendations and the prevention of sarcopenia. Current Opinion in Clinical Nutrition and Metabolic Care, 12, 86-90.
107. Pedersen, B. K. (2006). The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays in Biochemistry, 42, 105-117.
108. Pedersen, B. K. (2007). IL-6 signalling in exercise and disease. Biochemical Society Transactions, 35, 1295-1297.
109. Petrella, J. K., Kim, J. S., Cross, J. M., Kosek, D. J., Bamman, M. M. (2006). Efficacy of myonuclear addition may explain differential myofiber growth among resistance-trained young and older men and women. American Journal of Physiology Endocrinology and Metabolism, 291, E937-E946.
110. Phillips, S. M. (2006). Dietary protein for athletes: from requirements to metabolic advantage. Applied Physiology, Nutrition, and Metabolism, 31, 647-654.
111. Rabinovsky, E. D. & Draghia-Akli, R. (2004). Insulin-like growth factor I plasmid therapy promotes in vivo angiogenesis. Molecular Therapy, 9, 46-55.
112. Raue, U., Slivka, D., Jemiolo, B., Hollon, C., Trappe, S. (2007). Proteolytic gene expression differs at rest and after resistance exercise between young and old women. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 62, 1407-1412.
113. Rogers, M. A. & Evans, W. J. (1993). Changes in skeletal muscle with aging: effects of exercise training. Exercise and Sport Sciences Reviews, 21, 65-102.
114. Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., Glass, D. J. (2001). Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nature Cell Biology, 3, 1009-1013.
115. Roughead, Z. K., Johnson, L. K., Lykken, G. I., Hunt, J. R. (2003). Controlled high meat diets do not affect calcium retention or indices of bone status in healthy postmenopausal women. The Journal of Nutrition, 133, 1020-1026.
116. Sandmand, M., Bruunsgaard, H., Kemp, K., Andersen-Ranberg, K., Schroll, M., Jeune, B. (2003). High circulating levels of tumor necrosis factor-alpha in centenarians are not associated with increased production in T lymphocytes. Gerontology, 49, 155-160.
117. Sasaoka, T., Ishiki, M., Wada, T., Hori, H., Hirai, H., Haruta, T., Ishihara, H., Kobayashi, M. (2001). Tyrosine phosphorylation- dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis. Endocrinology, 142, 5226-5235.
118. Sattler, F. R., Castaneda-Sceppa, C., Binder, E. F., Schroeder, E. T., Wang, Y., Bhasin, S., Kawakubo, M., Stewart, Y., Yarasheski, K. E., Ulloor, J., Colletti, P., Roubenoff, R., Azen, S. P. (2009). Testosterone and growth hormone improve body composition and muscle performance in older men. The Journal of Clinical Endocrinology and Metabolism, 94, 1991-2001.
119. Schaap, L. A., Pluijm, S. M., Deeg, D. J., Visser, M. (2006). Inflammatory markers and loss of muscle mass (sarcopenia) and strength. The American Journal of Medicine, 119(526), e9-e17.
120. Schwander, J. C., Hauri, C., Zapf, J., Froesch, E. R. (1983). Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology, 113, 297-305.
121. Sekimoto, H. & Boney, C. M. (2003). C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signaling through Src in 3T3-L1 differentiation. Endocrinology, 144, 2546-2552.
122. Shavlakadze, T. & Grounds, M. D. (2003). Therapeutic interventions for age-related muscle wasting: importance of innervation and exercise for preventing sarcopenia. In S. Rattan (Ed.), Modulating aging and longevity. The Netherlands: Kluwer.
123. Shavlakadze, T. & Grounds, M. D. (2006). Of bears, frogs, meat, mice and men: insights into the complexity of factors affecting skeletal muscle atrophy/hypertrophy and myogenesis/adipogenesis. BioEssays, 28, 994-1009.
124. Shavlakadze, T., White, J. D., Davies, M., Hoh, J. F., Grounds, M. D. (2005a). Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophy. Neuromuscular Disorders, 15, 139-146.
125. Shavlakadze, T., Winn, N., Rosenthal, N., Grounds, M. D. (2005b). Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. Growth Hormone & IGF Research, 15, 4-18.
126. Shavlakadze, T., Boswell, J. M., Burt, D. W., Asante, E. A., Tomas, F. M., Davies, M. J., White, J. D., Grounds, M. D., Goddard, C. (2006). Rskalpha-actin/hIGF-1 transgenic mice with increased IGF-I in skeletal muscle and blood: impact on regeneration, denervation and muscular dystrophy. Growth Hormone & IGF Research, 16, 157-173.
127. Shemer, J., Adamo, M. L., Roberts, C. T. Jr., Leroith, D. (1992). Tissue-specific transcription start site usage in the leader exons of the rat insulin-like growth factor-I gene: evidence for differential regulation in the developing kidney. Endocrinology, 131, 2793-2799.
128. Sjogren, K., Liu, J. L., Blad, K., Skrtic, S., Vidal, O., Wallenius, V., Leroith, D., Tornell, J., Isaksson, O. G., Jansson, J. O., Ohlsson, C. (1999). Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proceedings of the National Academy of Sciences of the United States of America, 96, 7088-7092.
129. Sotiropoulos, A., Ohanna, M., Kedzia, C., Menon, R. K., Kopchick, J. J., Kelly, P. A., Pende, M. (2006). Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation. PNAS, 103, 7315-7320.
130. Stratikopoulos, E., Szabolcs, M., Dragatsis, I., Klinakis, A., Efstratiadis, A. (2008). The hormonal action of Igf1 in postnatal mouse growth. Proceedings of the National Academy of Sciences of the United States of America, 105, 19378-19383.
131. Strle, K., Broussard, S. R., Mccusker, R. H., Shen, W. H., Johnson, R. W., Freund, G. G., Dantzer, R., Kelley, K. W. (2004). Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide. Endocrinology, 145, 4592-4602.
132. Teglund, S., Mckay, C., Schuetz, E., Van Deursen, J. M., Stravopodis, D., Wang, D., Brown, M., Bodner, S., Grosveld, G., Ihle, J. N. (1998). Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell, 93, 841-850.
133. Thissen, J. P., Ketelslegers, J. M., Underwood, L. E. (1994). Nutritional regulation of the insulinlike growth factors. Endocrine Reviews, 15, 80-101.
134. Thomson, D. M. & Gordon, S. E. (2006). Impaired overload-induced muscle growth is associated with diminished translational signalling in aged rat fast-twitch skeletal muscle. Journal de Physiologie, 574, 291-305.
135. Tisdale, M. J. (2005). The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. The Journal of Supportive Oncology, 3, 209-217.
136. Tisdale, M. J. (2009). Mechanisms of cancer cachexia. Physiological Reviews, 89, 381-410.
137. Tuohimaa, P. (2009). Vitamin D and aging. The Journal of Steroid Biochemistry and Molecular Biology, 114, 78-84.
138. Udy, G. B., Towers, R. P., Snell, R. G., Wilkins, R. J., Park, S. H., Ram, P. A., Waxman, D. J., Davey, H. W. (1997). Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proceedings of the National Academy of Sciences of the United States of America, 94, 7239-7244.
139. Ullman, M., Ullman, A., Sommerland, H., Skottner, A., Oldfors, A. (1990). Effects of growth hormone on muscle regeneration and IGF-1 concentration in old rats. Acta Physiologica Scandinavica, 140, 521-525.
140. UM, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., Thomas, G. (2004). Absence of S6K1 protects against age- And diet-induced obesity while enhancing insulin sensitivity. Nature, 431, 200-205.
141. Veldhuis, J. D., Liem, A. Y., South, S., Weltman, A., Weltman, J., Clemmons, D. A., Abbott, R., Mulligan, T., Johnson, M. L., Pincus, S. (1995). Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. The Journal of Clinical Endocrinology and Metabolism, 80, 3209-3222.
142. Visser, M., Pahor, M., Taaffe, D. R., Goodpaster, B. H., Simonsick, E. M., Newman, A. B., Nevitt, M., Harris, T. B. (2002). Relationship of interleukin-6 and tumor necrosis factoralpha with muscle mass and muscle strength in elderly men and women: The Health ABC Study. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 57, M326-M332.
143. Welle, S., Bhatt, K., Shah, B., Thornton, C. (2002). Insulin-like growth factor-1 and myostatin mRNA expression in muscle: comparison between 62-77 and 21-31 yr old men. Experimental Gerontology, 37, 833-839.
144. Winn, N., Paul, A., Musaro, A., Rosenthal, N. (2002). Insulin-like growth factor isoforms in skeletal muscle aging, regeneration, and disease. Cold Spring Harbor Symposia on Quantitative Biology, 67, 507-518.
145. Wolfe, R. R., Miller, S. L., Miller, K. B. (2008). Optimal protein intake in the elderly. Clinical Nutrition, 27, 675-684.
146. Wong, M. S., Sriussadaporn, S., Tembe, V. A., Favus, M. J. (1997). Insulin-like growth factor I increases renal 1, 25(OH)2D3 biosynthesis during low-P diet in adult rats. The American Journal of Physiology, 272, F698-F703.
147. Wong, M. S., Tembe, V. A., Favus, M. J. (2000). Insulin-like growth factor-I stimulates renal 1, 25-dihydroxycholecalciferol synthesis in old rats fed a low calcium diet. The Journal of Nutrition, 130, 1147-1152.
148. Wurtman, J. J., Lieberman, H., Tsay, R., Nader, T., Chew, B. (1988). Calorie and nutrient intakes of elderly and young subjects measured under identical conditions. Journal of Gerontology, 43, B174-B180.
149. Yakar, S., Liu, J. L., Stannard, B., Butler, A., Accili, D., Sauer, B., Leroith, D. (1999). Normal growth and development in the absence of hepatic insulin-like growth factor I. Proceedings of the National Academy of Sciences of the United States of America, 96, 7324-7329.
150. Yang, S. Y. & Goldspink, G. (2002). Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Letters, 522, 156-160.
151. Yarasheski, K. E. (2003). Exercise, aging, and muscle protein metabolism. Journal of Gerontology: Medical Sciences, 58A, 918-922.
152. Yu, F., Degens, H., Larsson, L. (1999). The influence of thyroid hormone on myosin isoform composition and shortening velocity of single skeletal muscle fibres with special reference to ageing and gender. Acta Physiologica Scandinavica, 167(4), 313-316.
153. Zha, Y., Taguchi, T., Nazneen, A., Shimokawa, I., Higami, Y., Razzaque, M. S. (2008). Genetic suppression of GH-IGF-1 activity, combined with lifelong caloric restriction, prevents agerelated renal damage and prolongs the life span in rats. American Journal of Nephrology, 28, 755-764.